The global Cosmetic Implants Market was worth US$ 9.6 billion in 2021, and it is expected to grow to US$ 17.9 billion by 2032. During the forecast period, the trade is expected to grow at a 5.8% CAGR. Increasing expenditure on healthcare, growing awareness about cosmetic procedures, and an increasing number of specialty clinics and …
Category Archives: Healthcare Trends
Medical Bed Market in Japan is projected to secure a market value of US$ 325.4 Million by 2032
Increased investment in medical infrastructure is expected to propel the global medical bed market from US$ 3.4 billion in 2022 to US$ 5.5 billion in 2032. From 2022 to 2032, the Medical Bed Market is expected to grow at a 4.9% annual rate. In February 2022, the Government of New Delhi announced the establishment of …
Medical Polyetheretherketone is anticipated to reach a valuation of US$ 1158.26 Million by 2032 | FMI
The global Medical Polyetheretherketone Market is expected to reach a market valuation of US$ 572.54 Million by 2022, accelerating with a moderate CAGR of 7.3% by 2022-2032. The medical polyetheretherketone market size is anticipated to be valued at about US$ 1158.26 Million by 2032 end. Increased adoption of medical polyetheretherketone as a substitute for metals has …
European 3D Imaging Surgical Solution Market is growing at a significant CAGR, with a global market share of 27.9%
The 3D imaging surgical solution market is expected to reach a market value of US$ 264.6 million by 2032 while expanding its presence in the global market at a 6.2% CAGR (2022-2032). In 2022, the market is expected to generate US$ 137.2 million. Previously, the market grew at a slower CAGR of 5.6%. (2017-2021) 3D …
Laboratory Supplies Market is expected to reach a valuation of US$ 81.61 Billion by 2032 | FMI
Laboratory Supplies Market is projected to increase at a CAGR of 8% during the forecast period between 2022 and 2032, reaching a total of US$ 81.61 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6%. Rise in investment for …
Andersen Tawil Syndrome Treatment Market to reach US$ 4.2 Billion by 2033; Type-1 Treatment to comprise 59% of all Procedures | FMI Report
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to pharmaceutical companies, increasing …
Research and Development for Hutchinson Gilford progeria syndrome to Register 8.5% CAGR | FMI Study
During the forecast period 2023 to 2033, the Hutchinson Gilford progeria syndrome market is expected to grow at a value of 8.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Hutchinson Gilford progeria syndrome is expected to rise up to a market valuation of US$ 15,990 Million. Around 400 …
Thrombocytopenia Treatment Market Value to reach US$ 10 Billion by 2033, expected to surge at over 5% CAGR | FMI Report
A recently published study by FMI expects the global thrombocytopenia treatment market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 10 Billion is expected for the market. The thrombocytopenia treatment market is predicted to increase significantly, since patients with thrombocytopenia experience …
Global Marburg Virus Disease Therapeutics Market to surge at a 5.5% CAGR until 2033, reaching US$ 155 Million | FMI Report
During the forecast period 2023 to 2033, the Marburg virus disease therapeutics market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Marburg virus disease therapeutics is expected to rise up to a market valuation of US$ 155 Million. Growth of …
Oral segment constitutes the bulk of 45% in the Babesiosis Treatment Market in 2023, FMI Report
In 2023, the market for babesiosis treatments is projected to be worth US$1.21 billion. The overall market for babesiosis treatment is anticipated to grow at a CAGR of 5.0% between 2023 and 2033, reaching a value of approximately US$ 1.98 Billion by 2033 due to ongoing advancements in pharmaceuticals and biotechnology for the treatment of …